Skip to content
Open access

KCNE2 upregulation improves cardiac function by inhibiting Smurf1-mediated SERCA2a degradation in diabetic cardiomyopathy in mice

Jul 2026 · Acta Pharmacologica Sinica · Vol 47, pp. 2955 - 2968 · 0 citations · 48 references
Medicine

TL;DR

A novel protective role of KCNE2 is revealed in diabetic hearts and upregulation is proposed as a potential therapeutic strategy for DCM by suppressing Smurf1-mediated polyubiquitination and proteasomal degradation of SERCA2a.

Read PDF

Similar papers

Open access Aug 2026

POU2F1 promotes hypertensive cardiac fibrosis by regulating mitochondrial homeostasis through PINK1/Parkin-dependent mitophagy

Hypertension-induced cardiac fibrosis is a major risk factor for heart failure; although disrupted mitochondrial homeostasis has been confirmed to serve a critical role in the pathological process, its upstream regulatory factors remain incompletely understood. In the current study, RNA sequencing and bioinformatics an...

Yong-Bo Ma, Xiao-Zhe Chen, Zi-Xian Liu et al. · 0 citations
Aug 2026

RGS6 drives myocyte loss in the diabetic heart via a KLF4/miR-30e/CaMKII-dependent mechanism.

It is demonstrated that high glucose triggers regulator of G protein signaling 6 (RGS6) up-regulation in both human and murine cardiomyocytes, the hearts of hyperglycemic mice, and cardiac tissue samples from individuals with heart failure and a history of diabetes point to RGS6/KLF4 as key sources of pathogenic cardia...

Abhishek Singh Sengar, Sreemoyee Chakraborti, Anushree Lye et al. · 0 citations
Open access Aug 2026

SRPK3 exacerbates cardiac ischemia/reperfusion injury by regulating KLF3-mTOR/P70 S6K-mediated autophagy.

Myocardial ischemia-reperfusion (I/R) injury remains a leading cause of cardiac dysfunction and mortality worldwide. Serine/arginine-Rich Protein Kinase 3 (SRPK3) is highly expressed in cardiac muscle, yet its specific pathological role in I/R injury has not been fully characterized. In this study, we utilized cardiac-...

Yun Xing, Saiyang Xie, Nan Zhao et al. · 0 citations
Open access Sep 2026

METTL7B attenuates pathological cardiac hypertrophy via m6A-associated regulation of HK3.

Pathological cardiac hypertrophy is a major contributor to heart failure, yet the epitranscriptomic mechanisms that restrain maladaptive remodeling remain incompletely understood. In this study, we investigated the role of METTL7B and its association with m6A-related regulation of HK3 in pathological cardiac hypertroph...

Z. Bao, Zhi-Qiang Liu, Yu-Chun Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.